Karyopharm Therapeutics Inc (KPTI)
1.13
+0.05
(+4.63%)
USD |
NASDAQ |
May 03, 16:00
1.12
-0.01
(-0.88%)
After-Hours: 20:00
Karyopharm Therapeutics Cash and Short Term Investments (Quarterly): 191.44M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 191.44M |
September 30, 2023 | 208.32M |
June 30, 2023 | 236.76M |
March 31, 2023 | 260.38M |
December 31, 2022 | 277.97M |
September 30, 2022 | 148.38M |
June 30, 2022 | 170.85M |
March 31, 2022 | 205.31M |
December 31, 2021 | 228.62M |
September 30, 2021 | 204.21M |
June 30, 2021 | 235.89M |
March 31, 2021 | 224.36M |
December 31, 2020 | 249.24M |
September 30, 2020 | 263.04M |
June 30, 2020 | 296.72M |
March 31, 2020 | 352.13M |
December 31, 2019 | 261.96M |
September 30, 2019 | 267.53M |
June 30, 2019 | 217.16M |
March 31, 2019 | 264.42M |
December 31, 2018 | 328.20M |
September 30, 2018 | 206.77M |
Date | Value |
---|---|
June 30, 2018 | 241.12M |
March 31, 2018 | 130.92M |
December 31, 2017 | 146.47M |
September 30, 2017 | 119.41M |
June 30, 2017 | 143.45M |
March 31, 2017 | 109.88M |
December 31, 2016 | 129.55M |
September 30, 2016 | 126.81M |
June 30, 2016 | 122.74M |
March 31, 2016 | 136.42M |
December 31, 2015 | 175.63M |
September 30, 2015 | 195.24M |
June 30, 2015 | 221.19M |
March 31, 2015 | 246.41M |
December 31, 2014 | 205.72M |
September 30, 2014 | 227.13M |
June 30, 2014 | 132.31M |
March 31, 2014 | 144.89M |
December 31, 2013 | 155.97M |
September 30, 2013 | 52.93M |
June 30, 2013 | 61.67M |
December 31, 2012 | 0.391M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
148.38M
Minimum
Sep 2022
352.13M
Maximum
Mar 2020
236.86M
Average
235.89M
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Geron Corp | 443.05M |
Arbutus Biopharma Corp | 126.00M |
Verastem Inc | 137.13M |
Actinium Pharmaceuticals Inc | 84.06M |
Chimerix Inc | 182.84M |